Ramaswamy Aneesh K, Vorp David A, Weinbaum Justin S
Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States.
McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA, United States.
Front Cardiovasc Med. 2019 May 31;6:74. doi: 10.3389/fcvm.2019.00074. eCollection 2019.
Modern regenerative medicine, and tissue engineering specifically, has benefited from a greater appreciation of the native extracellular matrix (ECM). Fibronectin, collagen, and elastin have entered the tissue engineer's toolkit; however, as fully decellularized biomaterials have come to the forefront in vascular engineering it has become apparent that the ECM is comprised of more than just fibronectin, collagen, and elastin, and that cell-instructive molecules known as matricellular proteins are critical for desired outcomes. In brief, matricellular proteins are ECM constituents that contrast with the canonical structural proteins of the ECM in that their primary role is to interact with the cell. Of late, matricellular genes have been linked to diseases including connective tissue disorders, cardiovascular disease, and cancer. Despite the range of biological activities, this class of biomolecules has not been actively used in the field of regenerative medicine. The intent of this review is to bring matricellular proteins into wider use in the context of vascular tissue engineering. Matricellular proteins orchestrate the formation of new collagen and elastin fibers that have proper mechanical properties-these will be essential components for a fully biological small diameter tissue engineered vascular graft (TEVG). Matricellular proteins also regulate the initiation of thrombosis via fibrin deposition and platelet activation, and the clearance of thrombus when it is no longer needed-proper regulation of thrombosis will be critical for maintaining patency of a TEVG after implantation. Matricellular proteins regulate the adhesion, migration, and proliferation of endothelial cells-all are biological functions that will be critical for formation of a thrombus-resistant endothelium within a TEVG. Lastly, matricellular proteins regulate the adhesion, migration, proliferation, and activation of smooth muscle cells-proper control of these biological activities will be critical for a TEVG that recellularizes and resists neointimal formation/stenosis. We review all of these functions for matricellular proteins here, in addition to reviewing the few studies that have been performed at the intersection of matricellular protein biology and vascular tissue engineering.
现代再生医学,尤其是组织工程学,受益于对天然细胞外基质(ECM)更深入的认识。纤连蛋白、胶原蛋白和弹性蛋白已进入组织工程师的工具包;然而,随着完全脱细胞生物材料在血管工程中占据前沿地位,很明显细胞外基质不仅仅由纤连蛋白、胶原蛋白和弹性蛋白组成,而且被称为基质细胞蛋白的细胞指令分子对于实现理想结果至关重要。简而言之,基质细胞蛋白是细胞外基质的组成成分,与细胞外基质的典型结构蛋白不同,其主要作用是与细胞相互作用。最近,基质细胞基因已与包括结缔组织疾病、心血管疾病和癌症在内的多种疾病相关联。尽管这类生物分子具有广泛的生物活性,但在再生医学领域尚未得到积极应用。本综述的目的是在血管组织工程的背景下更广泛地应用基质细胞蛋白。基质细胞蛋白协调具有适当机械性能的新胶原蛋白和弹性纤维的形成——这些将是完全生物性小直径组织工程血管移植物(TEVG)的重要组成部分。基质细胞蛋白还通过纤维蛋白沉积和血小板激活来调节血栓形成的起始,以及在不再需要时血栓的清除——血栓形成的适当调节对于植入后维持TEVG的通畅至关重要。基质细胞蛋白调节内皮细胞的黏附、迁移和增殖——所有这些生物学功能对于在TEVG内形成抗血栓内皮至关重要。最后,基质细胞蛋白调节平滑肌细胞的黏附、迁移、增殖和激活——对这些生物学活性的适当控制对于重新细胞化并抵抗新内膜形成/狭窄的TEVG至关重要。我们在此回顾了基质细胞蛋白的所有这些功能,此外还回顾了在基质细胞蛋白生物学与血管组织工程交叉领域所进行的少数研究。